REAL-WORLD RETROSPECTIVE ANALYSIS OF TUMOR TREATING FIELDS IN THE TREATMENT OF HIGH-GRADE GLIOMA BASED ON CHINESE POPULATION

被引：0
|
作者：
Chen, Lingchao [1 ]
Chen, Junrui [2 ]
Song, Kun [1 ]
Nie, Jingtao [3 ]
Zhuang, Dongxiao [1 ]
Wang, Yang [1 ]
Yao, Yu [1 ]
Wu, Jinsong [2 ]
Qin, Zhiyong [1 ]
机构：
[1] Fudan Univ, Huashan Hosp, Shanghai, Peoples R China
[2] Huashan Hosp, Shanghai, Peoples R China
[3] ZaiLab Trading Shanghai Co Ltd, Shanghai, Peoples R China
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NCOG-14
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [31] FET PET RESPONSE UPON RADIOCHEMOTHERAPY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) IN A PATIENT WITH PROGRESSIVE HIGH-GRADE GLIOMA
    Kessler, A. F.
    Weiland, J.
    Linsenmann, T.
    Ernestus, R.
    Hagemann, C.
    Loehr, M.
    NEURO-ONCOLOGY, 2019, 21 : 81 - 81
  • [32] A PHASE 2 STUDY OF NIRAPARIB CONCOMITANT WITH TUMOR TREATING FIELDS (TTFIELDS) IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA (HGG)
    Bagley, S. J.
    Mansour, M.
    Pantel, A.
    Schubert, E.
    Dulal, C.
    Nabavizadeh, A.
    Mohan, S.
    Maloney, E.
    Prior, T.
    Angeloni, N.
    Blessing, C.
    Frangos, S.
    Coghlan, L.
    Wileyto, E. P.
    O'Rourke, D.
    Brem, S.
    Desai, A.
    NEURO-ONCOLOGY, 2023, 25
  • [33] Real-world direct healthcare costs of treating recurrent high-grade serous ovarian cancer with cytotoxic chemotherapy
    Gilbert, Lucy
    Ramanakumar, Agnihotram, V
    Festa, Maria Carolina
    Jardon, Kris
    Zeng, Xing
    Martins, Claudia
    Shbat, Layla
    Alsoud, Marwa Abo
    Borod, Manuel
    Wolfson, Michael
    Papaioannou, Ioanna
    Basso, Olga
    Sampalis, John
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (08) : 537 - 551
  • [34] Erratum to: Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis
    Valentina Pinzi
    Chiara Orsi
    Marcello Marchetti
    Ida Maddalena Milanesi
    Livia Corinna Bianchi
    Francesco DiMeco
    Valeria Cuccarini
    Mariangela Farinotti
    Paolo Ferroli
    Gaetano Finocchiaro
    Angelo Franzini
    MariaLuisa Fumagalli
    Antonio Silvani
    Laura Fariselli
    Neurological Sciences, 2015, 36 : 1085 - 1085
  • [35] A PHASE I TRIAL OF TUMOR TREATING FIELDS WITH AND WITHOUT CONCOMITANT TEMOZOLOMIDE AND BEVACIZUMAB IN PEDIATRIC PATIENTS WITH HIGH-GRADE GLIOMA AND EPENDYMOMA
    Hanson, Derek
    NEURO-ONCOLOGY, 2018, 20 : 202 - 203
  • [36] Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
    Wenyin Shi
    Deborah T. Blumenthal
    Nancy Ann Oberheim Bush
    Sied Kebir
    Rimas V. Lukas
    Yoshihiro Muragaki
    Jay-Jiguang Zhu
    Martin Glas
    Journal of Neuro-Oncology, 2020, 148 : 489 - 500
  • [37] Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
    Shi, Wenyin
    Blumenthal, Deborah T.
    Bush, Nancy Ann Oberheim
    Kebir, Sied
    Lukas, Rimas, V
    Muragaki, Yoshihiro
    Zhu, Jay-Jiguang
    Glas, Martin
    JOURNAL OF NEURO-ONCOLOGY, 2020, 148 (03) : 489 - 500
  • [38] Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice
    Shi, W.
    Blumenthal, D.
    Oberheim, N. A.
    Kebir, S.
    Lukas, R. V.
    Muragaki, Y.
    Zhu, J. J.
    Glas, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E697 - E697
  • [39] Post-marketing safety surveillance of tumor treating fields (TTFields) in patients with high-grade glioma in clinical practice.
    Shi, Wenyin
    Blumenthal, Deborah T.
    Bush, Nancy Ann Oberheim
    Kebir, Sied
    Lukas, Rimas, V
    Muragaki, Yoshihiro
    Zhu, Jay-Jiguang
    Glas, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] EFFECT OF TUMOR TREATING FIELDS IN CHILDREN WITH RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMA AND EPENDYMOMA (PEDIATRIC BRAIN TUMOR CONSORTIUM PBTC048)
    Goldman, Stewart
    NEURO-ONCOLOGY, 2018, 20 : 97 - 97
12345